Oseltamivir-resistant influenza A pandemic (H1N1) 2009 virus in northern Greece

Hippokratia

Volumn 15, Issue 3, 2011, Pages 272-274

  Gioula, G ^a   Melidou, A ^a   Exindari, M ^a   Papoutsi, N ^a   Chatzidimitriou, D ^a   Dotis, J ^a   Malisiovas, M ^a  

^a ARISTOTLE UNIVERSITY OF THESSALONIKI   (Greece)

Author keywords

Northern Greece; Oseltamivir resistant; Pandemic influenza A (H1N1) 2009 virus

Indexed keywords

INFLUENZA VACCINE; OSELTAMIVIR; VIRUS SIALIDASE;

2009 H1N1 INFLUENZA; ADOLESCENT; ARTICLE; CASE REPORT; CHILD; FEMALE; GREECE; HUMAN; LABORATORY TEST; NONHUMAN; NUCLEOTIDE SEQUENCE; PANDEMIC INFLUENZA; PHYSICAL EXAMINATION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SCHOOL CHILD; SEASONAL INFLUENZA; VIRUS ISOLATION; VIRUS MUTATION; VIRUS RESISTANCE; VIRUS STRAIN;

EID: 79959856463     PISSN: 11084189     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (14)

1. Garten RJ, Davis CT, Russell CA, Shu B, Lindstrom S, Balish A, et al. Antigenic and genetic characteristics of swine-origin 2009 A (H1N1) influenza viruses circulating in humans. Science. 2009; 325: 197-201.
2. World Health Organization [homepage on the internet]. Weekly virological surveillance update. Pandemic (H1N1) 2009-update 92, 2010 [updated 2010 March; cited 2010 March]. Available from: http://www.who.int/csr/disease/swineflu/ laboratory19_03_2010/en
3. Centre for Disease Prevention and Control. Drug susceptibility of swine-origin influenza A (H1N1) viruses, April 2009. MMWR 2009; 58: 433-435.
4. Moscona A. Neuraminidase inhibitors for influenza. N Engl J Med. 2005; 353: 1363-1373.
5. Centre for Disease Prevention and Control [homepage on the internet]. First isolation of a secondary oseltamivir-resistant A (H1N1)v strain in Denmark, Stockholm, Sweden, 2009. Available from: http://www.ecdc.europa.eu/en/healthtopics/ Documents/0906_Influenza_AH1N1_ECDC_Threat_Assessment_ First_isolation_of_a_secondary_oseltmivir_resistant_ strain_in_Denmark.pdf
6. World Health Organization. Update on oseltamivir-resistant pandemic A (H1N1) 2009 influenza virus: January 2010. WER. 2010; 85: 37-48.
7. Gianella A, Walter A, Revollo R, Loayza R, Vargas J, Roca Y. Epidemiological analysis of the influenza A(H1N1)v outbreak in Bolivia, May-August 2009. Euro Surveill. 2009; 14: 19323.
8. Lytras T, Theocharopoulos G, Tsiodras S, Mentis A, Panagiotopoulos T, Bonovas S; influenza surveillance report group. Enhanced surveillance of influenza A(H1N1)v in Greece during the containment phase. Euro Surveill. 2009;14: 19275.
9. World Health Organization. Outbreak news-Swine Influenza WER 2009; 84: 149-160.
10. Centre of Disease Control. CDC Real-time RT-PCR protocol for detection and characterization of swine influenza (version 2009), CDC ref: #I-007-05
11. Chen H, Cheung CL, Tai H, Zhao P, Chan JF, Cheng VC, et al. Oseltamivir-resistant influenza A pandemic (H1N1) 2009 virus, Hong Kong, China. Emerg Infect Dis. 2009; 15:1970-1972.
12. Yang JR, Huang YP, Lin YC, Su CH, Kuo CY, Hsu LC, et al. Early findings of oseltamivir-resistant pandemic (H1N1) 2009 influenza A viruses in Taiwan. Antiviral Res. 2010 Sep 24. [Epub ahead of print]
13. Valinotto LE, Diez RA, Barrero PR, Farías JA, López EL, Mistchenko AS. Emergence of intratreatment resistance to oseltamivir in pandemic influenza A H1N1 2009 virus. Antivir Ther. 2010;15:923-927.
14. Kiso M, Shinya K, Shimojima M, Takano R, Takahashi K, Katsura H, et al. Characterization of oseltamivir-resistant 2009 H1N1 pandemic influenza A viruses. PLoS Pathog. 2010;6: e1001079.